Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

NAV CV​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

NAV CV​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

NAVCO Pharmaceuticals Inc(NAV CV)

$0.01+0.000.00%(Market Closed · 21:10:05 UTC)
ProfileFinancialsChartingEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingEmployees

NAVCO Pharmaceuticals Inc(NAV CV)

$0.01+0.000.00%(Market Closed · 21:10:05 UTC)
ProfileFinancialsChartingEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingEmployees
Ask AI

NAVCO Pharmaceuticals Inc — Company Profile

Navco Pharmaceuticals, Inc. engages in the manufacture and research of nano-technology products and materials. It uses Computerized Nano-meter Algorithms. The company was founded by Marek Jasinski on April 21, 2018 and is headquartered in Burlington, Canada.

Sector
Health Care
Industry
Pharmaceuticals
Exchange
CV
CEO
Geoffrey Lee
Headquarters
Vancouver, BC, CA
IPO Date
Nov 8, 2018
Website
navcopharma.com

Key Metrics

Price
$0.00
Market Cap
$0.00
Revenue (TTM)
$0.00
Net Income (TTM)
$0.00
EPS (TTM)
0.00
P/E (TTM)
0.00
P/B (TTM)
0.00
Dividend Yield
0.00%
ROE (TTM)
0.00%
ROA (TTM)
0.00%
Operating Margin
0.00%
Beta
0.00

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Navco Pharmaceuticals, Inc. engages in the manufacture and research of nano-technology products and materials. It uses Computerized Nano-meter Algorithms. The company was founded by Marek Jasinski on April 21, 2018 and is headquartered in Burlington, Canada.

Website
navcopharma.com
Location
Vancouver, BC, CA
Employees0
CEOGeoffrey Lee
Sector
Health Care
Industry
Pharmaceuticals
IPO DateNov 8, 2018

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Key Stats

Trading

Px/Chg 1D$0.00 / +0.00%
52 Wk H$0.00
52 Wk L$0.00
Avg Volume0.00
Beta0.00
Mkt Cap0.00

Float

0
Short Float0.00%
Days to Cover0.00
Stock Repurchased$0.00

Estimates

P/E0.00
Est P/E0.00
Est EPS0.00
Est PEG0.00

Enterprise Value Bridge

Metric13 Nov '26
Price (As of 13 Nov '26)0.01
Basic Shares57.07
Market Cap0.3
−In-the-Money Convertible Debt—
+Operating Leases—
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Pension Liabilities—
Enterprise Value0.3

Related companies

Eli Lilly and Company

LLY US

Johnson & Johnson

JNJ US

AbbVie Inc.

ABBV US

Merck & Co., Inc.

MRK US

Novartis Ag

NVS US

Astrazeneca Plc

AZN US

Abbott Laboratories

ABT US

Novo Nordisk A/S

NVO US

Pfizer Inc

PFE US

Vertex Pharmaceuticals Inc / Ma

VRTX US

Bristol Myers Squibb Company

BMY US

Csl Ltd

CSLLY US

Ask AI

NAVCO Pharmaceuticals Inc — Company Profile

Navco Pharmaceuticals, Inc. engages in the manufacture and research of nano-technology products and materials. It uses Computerized Nano-meter Algorithms. The company was founded by Marek Jasinski on April 21, 2018 and is headquartered in Burlington, Canada.

Sector
Health Care
Industry
Pharmaceuticals
Exchange
CV
CEO
Geoffrey Lee
Headquarters
Vancouver, BC, CA
IPO Date
Nov 8, 2018
Website
navcopharma.com

Key Metrics

Price
$0.00
Market Cap
$0.00
Revenue (TTM)
$0.00
Net Income (TTM)
$0.00
EPS (TTM)
0.00
P/E (TTM)
0.00
P/B (TTM)
0.00
Dividend Yield
0.00%
ROE (TTM)
0.00%
ROA (TTM)
0.00%
Operating Margin
0.00%
Beta
0.00

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Navco Pharmaceuticals, Inc. engages in the manufacture and research of nano-technology products and materials. It uses Computerized Nano-meter Algorithms. The company was founded by Marek Jasinski on April 21, 2018 and is headquartered in Burlington, Canada.

Website
navcopharma.com
Location
Vancouver, BC, CA
Employees0
CEOGeoffrey Lee
Sector
Health Care
Industry
Pharmaceuticals
IPO DateNov 8, 2018

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Key Stats

Trading

Px/Chg 1D$0.00 / +0.00%
52 Wk H$0.00
52 Wk L$0.00
Avg Volume0.00
Beta0.00
Mkt Cap0.00

Float

0
Short Float0.00%
Days to Cover0.00
Stock Repurchased$0.00

Estimates

P/E0.00
Est P/E0.00
Est EPS0.00
Est PEG0.00

Enterprise Value Bridge

Metric13 Nov '26
Price (As of 13 Nov '26)0.01
Basic Shares57.07
Market Cap0.3
−In-the-Money Convertible Debt—
+Operating Leases—
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Pension Liabilities—
Enterprise Value0.3

Related companies

Eli Lilly and Company

LLY US

Johnson & Johnson

JNJ US

AbbVie Inc.

ABBV US

Merck & Co., Inc.

MRK US

Novartis Ag

NVS US

Astrazeneca Plc

AZN US

Abbott Laboratories

ABT US

Novo Nordisk A/S

NVO US

Pfizer Inc

PFE US

Vertex Pharmaceuticals Inc / Ma

VRTX US

Bristol Myers Squibb Company

BMY US

Csl Ltd

CSLLY US